Kimberleigh Lillard

Kimberleigh Lillard is a Clinical Trials Scientific Affairs Analyst at ACM Global Laboratories since August 2021, with prior experience as a Clinical Scientist at Amerimmune, where work focused on immunophenotyping assays and COVID-19 research. Previously, Kimberleigh served as a Medical Technologist II at Quest Diagnostics Nichols Institute, conducting various LCMS assays and instrument maintenance. Early career roles included Resident Advisor and Undergraduate Research Assistant at George Mason University, where Kimberleigh managed student residence halls and contributed to research on fingerprint demographics. Education includes a Master of Science in Forensic Science and a Bachelor's Degree in Forensic Science, both from George Mason University.